greeksoup/ stock research

Precigen (PGEN) FY2023 results: revenue $6 million, down 76.9% on the year

Precigen, Inc. (PGEN) reported revenue of $6 million for fiscal 2023, the year ended 31 December 2023, down 76.9% on the year before. Net income was -$96 million, and diluted earnings per share $-0.39. The figures are the company's own, from the 10-K it filed with the SEC on 25 March 2026.

Revenue
$6 million
-76.9% on the year
FY2016FY2023
Operating margin
-1602.5%
FY2016FY2023
Net income
-$96 million
FY2016FY2023
Diluted EPS
-$0.39
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The quarters: Q1 FY2023 · Q2 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue6.226.914.3-76.9%
Research and development48.6n/an/a
Selling, general and administrative40.4n/an/a
Operating income-99.8n/an/a
Operating margin-1602.5%n/an/a
Interest expense0.5n/an/a
Pre-tax income-96.4-80.0-111
Income tax-0.5-0.2-0.2
Net income-95.928.3-92.2
Net margin-1540.6%105.2%-646.0%
Diluted EPS-$0.39$0.14-$0.47
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow-66.9-65.0-55.8
Capital expenditure1.54.97.2-68.8%
Free cash flow-68.5-70.0-63.0
Free cash flow margin-1099.9%-260.0%-441.7%
Cash from investing-3.1226-74.5
Cash from financing29.6-155121
Depreciation and amortisation6.710.813.8-38.1%
Share-based compensation9.910.213.9-3.1%
Diluted shares, weighted245m200m198m+22.0%
Shares outstanding at period end249m208m207m+19.6%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity118126107-6.1%
Redeemable equity0.00.0n/a
Short-term borrowingsn/a43.2n/a
Debt0.043.2180
Operating lease liabilities5.97.08.7-15.7%
Other liabilities26.6n/a63.8
Total liabilities and equity151216360-30.1%
Fixed assets7.17.38.6-3.0%
Goodwill26.636.937.6-27.9%
Intangible assets40.744.552.3-8.4%
Investments55.351.1121+8.2%
Cash and equivalents7.64.936.4+56.0%
Receivables0.91.01.3-7.8%
Other assets12.970.3103-81.7%
Total assets151216360-30.1%

10-K for the year ended 31 December 2023, filed 25 March 2026: the filing.